brequinar has been researched along with vidofludimus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Baumgartner, R; Gassen, M; Kralik, M; Leban, J; Mies, J; Tasler, S | 1 |
| Kadir, MFA; Nellore, K; Othman, S | 1 |
| Chadwick, AE; French, NS; Jones, SW; Park, BK; Penman, SL | 1 |
3 other study(ies) available for brequinar and vidofludimus
| Article | Year |
|---|---|
Biphenyl-4-ylcarbamoyl thiophene carboxylic acids as potent DHODH inhibitors.
Topics: Biphenyl Compounds; Carbamates; Carboxylic Acids; Dihydroorotate Dehydrogenase; Drug Design; Enzyme Inhibitors; Humans; Molecular Structure; Oxidoreductases Acting on CH-CH Group Donors; Quantitative Structure-Activity Relationship; Recombinant Proteins; Structure-Activity Relationship; Thiophenes | 2006 |
Dihydroorotate Dehydrogenase Inhibitors Promote Cell Cycle Arrest and Disrupt Mitochondria Bioenergetics in Ramos Cells.
Topics: Biphenyl Compounds; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dicarboxylic Acids; Dihydroorotate Dehydrogenase; Energy Metabolism; Humans; Membrane Potential, Mitochondrial; Mitochondria; Neoplasms; Oxidoreductases Acting on CH-CH Group Donors | 2020 |
Investigating dihydroorotate dehydrogenase inhibitor mediated mitochondrial dysfunction in hepatic in vitro models.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Biphenyl Compounds; Cell Line; Cell Respiration; Crotonates; Dicarboxylic Acids; Dihydroorotate Dehydrogenase; Humans; Hydroxybutyrates; Immunosuppressive Agents; Leflunomide; Liver; Mitochondria; Models, Biological; Nitriles; Oxidoreductases Acting on CH-CH Group Donors; Salicylanilides; Toluidines; Triazoles | 2021 |